Cleared Traditional

K231708 - Axoguard HA+ Nerve Protector (AGHA12) (FDA 510(k) Clearance)

Also includes:
Axoguard HA+ Nerve Protector (AGHA22) Axoguard HA+ Nerve Protector (AGHA24) Axoguard HA+ Nerve Protector (AGHA36) Axoguard HA+ Nerve Protector (AGHA48)
Oct 2023
Decision
122d
Days
Class 2
Risk

K231708 is an FDA 510(k) clearance for the Axoguard HA+ Nerve Protector (AGHA12). This device is classified as a Cuff, Nerve (Class II - Special Controls, product code JXI).

Submitted by Axogen Corporation (Alachua, US). The FDA issued a Cleared decision on October 12, 2023, 122 days after receiving the submission on June 12, 2023.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.5275.

Submission Details

510(k) Number K231708 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 12, 2023
Decision Date October 12, 2023
Days to Decision 122 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code JXI - Cuff, Nerve
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.5275